Eisai bites back against restricted coverage plan for Aduhelm

Eisai bites back against restricted coverage plan for Aduhelm

Source: 
Pharmaforum
snippet: 

Japanese drugmaker Eisai has published comments filed with the US Centers for Medicare & Medicaid Services over its restrictive coverage proposal for beleaguered Alzheimer’s drug Aduhelm, saying it undermines well-established FDA processes.